This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Cornell University. Active years: 2008-2011.
Company Filing History:
Years Active: 2008-2011
Title: Innovations of Sergey V Shmelkov in Stem Cell Research
Introduction
Sergey V Shmelkov is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of stem cell research, holding a total of 2 patents. His work focuses on the identification and utilization of specific markers for stem and progenitor cells, which has important implications for medical treatments.
Latest Patents
One of his latest patents is titled "Slitrks as markers for stem and progenitor cells and methods of use thereof." This invention relates to slitrk proteins as markers of stem and progenitor cells, including embryonic stem cells and hematopoietic stem and progenitor cells. It also addresses their role as markers for leukemia and lymphoma cells, as well as endothelial cells. The patent provides methods for purifying slitrk-positive cells, detecting these cells, and creating therapeutic compositions that include purified slitrk-positive cells. Additionally, it outlines methods for targeting therapeutic agents to these cells and administering them to subjects in need.
Another significant patent is "Stem cell-specific promoters and their use." This invention describes a method for isolating stem cells from a mixed population of different cell types. The method involves selecting a promoter that functions exclusively in stem cells, allowing for the identification and separation of these cells from others in the population. The patent also discusses the potential for using these nucleic acid constructs in transgenic animals to monitor stem cell movement and address disorders mediated by stem cell proliferation.
Career Highlights
Sergey V Shmelkov is affiliated with Cornell University, where he continues to advance research in stem cell biology. His innovative approaches have garnered attention in the scientific community, contributing to a deeper understanding of stem cell dynamics and their therapeutic potential.
Collaborations
He has collaborated with notable colleagues, including Shahin Rafii and Till Milde, further enhancing the impact of his research through shared expertise and insights.
Conclusion
Sergey V Shmelkov's contributions to stem cell research through his patents and collaborations highlight the importance of innovation in the medical field. His work not only advances scientific knowledge but also paves the way for potential therapeutic applications.